deferoxamine has been researched along with Bowen Disease in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choudry, K | 1 |
Brooke, RC | 1 |
Farrar, W | 1 |
Rhodes, LE | 1 |
Fijan, S | 1 |
Hönigsmann, H | 1 |
Ortel, B | 1 |
1 trial available for deferoxamine and Bowen Disease
Article | Year |
---|---|
The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Car | 2003 |
1 other study available for deferoxamine and Bowen Disease
Article | Year |
---|---|
Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine.
Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Deferoxamine; Female; Humans; Keratosis | 1995 |